| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO And President | Sell | 1,603 | $187.95 | $301,283.85 | -1.0% | |
| Oct 20, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew | Executive Chairman | Sell | 10,000 | $190.00 | $1,900,000.00 | -66.7% | |
| Oct 20, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J | Pres. &Chief Exec. Officer | Sell | 1,339 | $22.44 | $30,047.16 | -2.1% | |
| Oct 17, 2025 | GH Guardant Health, Inc. | Tariq Musa | Director | Sell | 116 | $66.95 | $7,766.20 | -1.5% | |
| Oct 17, 2025 | GH Guardant Health, Inc. | Potter Myrtle S | Director | Sell | 26 | $66.95 | $1,740.70 | -0.1% | |
| Oct 17, 2025 | MYNZ Mainz Biomed N.V. | Donahue Kevin Michael | 10% Owner | Buy | 643,850 | $0.00 | - | New | |
| Oct 17, 2025 | NTRA Natera, Inc. | Sheena Jonathan | Director, Co-founder | Sell | 4,570 | $176.60 | $807,041.87 | -0.4% | |
| Oct 16, 2025 | NEO Neogenomics Inc | Olivo Alicia C | EVP, GC &Business Development | Sell | 4,918 | $10.00 | $49,180.00 | -10.3% | |
| Oct 16, 2025 | XGN Exagen Inc. | Aballi John | President And CEO | Sell | 31,787 | $11.82 | $375,598.37 | -4.3% | |
| Oct 16, 2025 | GRAL Grail, Inc. | Ofman Joshua J. | President | Sell | 14,979 | $78.47 | $1,175,393.81 | -1.9% | |
| Oct 15, 2025 | GRAL Grail, Inc. | Ragusa Robert P | Chief Executive Officer | Sell | 7,239 | $68.88 | $498,622.32 | -1.0% | |
| Oct 9, 2025 | EXAS Exact Sciences Corp | Doyle James Edward | Director | Sell | 2,000 | $60.00 | $120,000.00 | -3.3% | |
| Oct 9, 2025 | TWST Twist Bioscience Corp | Laponis Adam | Chief Financial Officer | Sell | 5,517 | $31.96 | $176,314.67 | -2.9% | |
| Oct 9, 2025 | EXAS Exact Sciences Corp | Herriott James | SVP, General Counsel &Sec | Sell | 1,500 | $60.00 | $90,000.00 | -9.6% | |
| Oct 6, 2025 | TWST Twist Bioscience Corp | Cho Dennis | See Remarks | Sell | 3,876 | $32.19 | $124,756.81 | -3.8% | |
| Oct 6, 2025 | GRAL Grail, Inc. | Ofman Joshua J. | President | Sell | 81,385 | $62.50 | $5,086,562.50 | -17.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.